Your browser doesn't support javascript.
loading
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
Abaza, Yasmin; Kantarjian, Hagop; Garcia-Manero, Guillermo; Estey, Elihu; Borthakur, Gautam; Jabbour, Elias; Faderl, Stefan; O'Brien, Susan; Wierda, William; Pierce, Sherry; Brandt, Mark; McCue, Deborah; Luthra, Rajyalakshmi; Patel, Keyur; Kornblau, Steven; Kadia, Tapan; Daver, Naval; DiNardo, Courtney; Jain, Nitin; Verstovsek, Srdan; Ferrajoli, Alessandra; Andreeff, Michael; Konopleva, Marina; Estrov, Zeev; Foudray, Maria; McCue, David; Cortes, Jorge; Ravandi, Farhad.
Afiliação
  • Abaza Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Estey E; Department of Hematology, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Faderl S; Department of Hematology/Oncology, Hackensack University Medical Center, Hackensack, NJ.
  • O'Brien S; Department of Hematology/Oncology, University of California, Irvine, CA.
  • Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Brandt M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • McCue D; Department of Pharmacy, and.
  • Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kornblau S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Foudray M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • McCue D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Cortes J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blood ; 129(10): 1275-1283, 2017 03 09.
Article em En | MEDLINE | ID: mdl-28003274
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Promielocítica Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article